Find Federal Grants
Rapid Assessment of Drug Abuse: Smart City Tools (R41/R42 - Clinical Trial Optional)
National Institutes of Health · RFA-DA-20-020
National Institutes of Health · PAR-19-281
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
National Institutes of Health · PAR-19-282
Private Sector Partnership Addressing Emerging Zoonoses and Antimicrobial Resistance
Agency for International Development · GH-BAA-2018-ADDENDUM02
Centers for Disease Control - NCHHSTP · CDC-RFA-PS20-2002
Health Resources and Services Administration · HRSA-19-109
Planning Grant for Fogarty HIV Research Training Program for Low- and Middle-Income Country Institutions (D71 Clinical Trial Not Allowed)
National Institutes of Health · PAR-19-284
Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional)
National Institutes of Health · PAR-19-283
Infrastructure Development Training Programs for Critical HIV Research at Low-and Middle-Income Country Institutions (G11 Clinical Trials Not Allowed)
National Institutes of Health · PAR-19-285
Technical Assistance for Response to Public Health or Healthcare Crises: OPIOID SUPPLEMENTAL
Centers for Disease Control - OSTLTS · CDC-RFA-OT18-18040101SUPP19
Digital Health Technologies to Address the Social Determinants of Health in context of Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional)
National Institutes of Health · RFA-DA-20-018
Digital Health Technologies to Address the Social Determinants of Health in context of Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional)
National Institutes of Health · RFA-DA-20-017
Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R21 Clinical Trial Optional)
National Institutes of Health · PAR-19-280
Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R01 Clinical Trial Optional)
National Institutes of Health · PAR-19-279
Centers Without Walls for Collaborative Research in the Epilepsies: Functional Evaluation of Human Genetic Variants (U54 Clinical Trial Not Allowed)
National Institutes of Health · RFA-NS-19-019
National Park Service · P19AS00150
Pragmatic Trials of Managing Multimorbidity in Alzheimer's Disease (R61/R33 Clinical Trial Required)
National Institutes of Health · RFA-AG-20-029
Summer Research Training in Aging for Medical Students (T35 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AG-20-008
Exploiting Genome or Epigenome Editing to Functionally Validate Genes or Variants Involved in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed)
National Institutes of Health · PAR-19-278
National Institutes of Health · RFA-DA-20-011